The global oral anti-diabetic drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The significant growth in the market can be attributed to factors such as the rising prevalence of diabetes and the increasing number of programs initiated by various health organizations related to health awareness. In 2019, it was estimated that out of 511 million people suffering from diabetes, 31.3% were undiagnosed. In 2019, diabetes was the cause of 4.2 million deaths per year, making it the eighth leading cause of death, globally. The diabetic condition, on the whole, doubles the risk of death. Currently, about 10% of all diabetes cases are Type-1 and the remaining are of Type-2. Thus, the rise in the prevalence of type-2 diabetes globally is likely to create a vast demand for diabetes drugs during the forecast period.
To Request a Sample of our Report on Global Oral Anti Diabetic Drug Market: https://www.omrglobal.com/request-sample/oral-anti-diabetic-drug-market
The global oral anti-diabetic drug market analysis includes some of the key market players such as Sanofi S.A., Eli Lilly and Company, AstraZeneca plc., Astellas Pharma Inc., and Johnson & Johnson (Janss en Pharmaceuticals), among others. To maintain a strong position in the market, the market players are adopting various strategic moves, such as product launches, partnerships, collaborations, and mergers and acquisitions. In May 2018, Oramed started working to bring the first oral insulin product to market, providing a more convenient, effective and safer method for delivering insulin therapy.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Bausch Health Companies Inc., Nestlé (Galderma), Leo Pharma Inc., Hovione FarmaCiencia SA, and Aclaris Therapeutics, among others.
A full Report of Global Oral Anti Diabetic Drug Market is Available @ https://www.omrglobal.com/industry-reports/oral-anti-diabetic-drug-market
Global Oral Anti Diabetic Drug Market by Segment
By Drugs
- Biguanides
- Alpha-glucosidase inhibitors
- Dopamine-D2 receptor agonists
- Sodium-glucose Cotransport -2 (SGLT-2) inhibitor
- Dipeptidyl Peptidase – 4 (DPP-4) Inhibitors
- Sulfonylureas
- Meglitinides
Global Oral Anti Diabetic Drug Market by Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/oral-anti-diabetic-drug-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
